$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Clinical relevance of the CYP2D6 polymorphism for the treatment of psychiatric disorders

International congress series, v.1244, 2002년, pp.11 - 20  

Bertilsson, Leif (Tel.: +46-8-585-810-71)

Abstract AI-Helper 아이콘AI-Helper

AbstractIn 1980, we published two papers of importance for the future of our research: (i) it was shown that the two polymorphic hydroxylations of debrisoquine and sparteine are catalysed by a common enzyme now called CYP2D6 and (ii) that this polymorphic enzyme also catalysed the metabolism of the ...

주제어

참고문헌 (38)

  1. Life Sci. Hammer 6 1895 1967 10.1016/0024-3205(67)90218-4 Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds 

  2. Br. Med. J. Alexanderson 4 764 1969 10.1136/bmj.4.5686.764 Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy 

  3. Life Sci. Bertilsson 27 1673 1980 10.1016/0024-3205(80)90642-6 Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man 

  4. Bertilsson 15 2001 Interindividual Variability in Drug Metabolism in Humans Interethnic differences is drug disposition and effects 

  5. Trends Pharmacol. Sci. Ingelman-Sundberg 20 324 1999 10.1016/S0165-6147(99)01363-2 Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment 

  6. Br. J. Clin. Pharmacol. Bertilsson 53 111 2002 10.1046/j.0306-5251.2001.01548.x Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs 

  7. Lancet Mahgoub 2 584 1977 10.1016/S0140-6736(77)91430-1 Polymorphic hydroxylation of debrisoquine in man 

  8. Lancet Tucker 2 718 1977 10.1016/S0140-6736(77)90527-X Polymorphic hydroxylation of debrisoquine in man 

  9. Eur. J. Clin. Pharmacol. Eichelbaum 16 183 1979 10.1007/BF00562059 Defective N-oxidation of sparteine in man: a new pharmacogenetic defect 

  10. Clin. Pharmacol. Ther. Eichelbaum 31 184 1982 10.1038/clpt.1982.29 Polymorphic oxidation of sparteine and debrisoquine. Related pharmacogenetic entities 

  11. Eur. J. Clin. Pharmacol. Alvan 39 533 1990 10.1007/BF00316090 Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations 

  12. Clin. Pharmacol. Ther. Bertilsson 51 388 1992 10.1038/clpt.1992.38 Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquine and S-mephenytoin 

  13. Br. J. Clin. Pharmacol. Sohn 32 504 1991 10.1111/j.1365-2125.1991.tb03939.x Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations 

  14. Clin. Pharmacol. Ther. Dahl 51 12 1992 10.1038/clpt.1992.2 Analysis of the CYP2D6 gene in relation to debrisoquine and desipramine hydroxylation in a Swedish population 

  15. Mol. Pharmacol. Johansson 46 452 1994 Genetic analysis of the Chinese CYP2D locus. Characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation 

  16. Br. J. Clin. Pharmacol. Masimirembwa 42 713 1996 10.1046/j.1365-2125.1996.00489.x A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity 

  17. Proc. Natl. Acad. Sci. U. S. A. Johansson 90 11825 1993 10.1073/pnas.90.24.11825 Inherited amplification of an active gene in the cytochrome P450 CYP2D-locus as a cause of ultrarapid metabolism of debrisoquine 

  18. Ther. Drug Monit. Bertilsson 7 478 1985 10.1097/00007691-198512000-00021 Extremely rapid hydroxylation of debrisoquine-a case report with implication for treatment with nortriptyline and other tricyclic antidepressants 

  19. Lancet Bertilsson 341 63 1993 10.1016/0140-6736(93)92546-6 Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine 

  20. J. Pharmacol. Exp. Ther. Dahl 274 516 1995 Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis 

  21. Pharmacogenetics Bernal 9 657 1999 10.1097/00008571-199910000-00013 Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine 

  22. Clin. Pharmacol. Ther. Agundez 57 265 1995 10.1016/0009-9236(95)90151-5 Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population 

  23. Psychopharmacology Scordo 147 300 1999 10.1007/s002130051171 Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxy risperidone 

  24. J. Pharmacol. Exp. Ther. Aklillu 278 441 1996 Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles 

  25. Pharmacogenetics Nishida 10 567 2000 10.1097/00008571-200008000-00010 CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D*10 

  26. Clin. Pharmacol. Ther. Mellstrom 30 189 1981 10.1038/clpt.1981.147 E- and Z-hydroxylation of nortriptyline in man - relationship to polymorphic hydroxylation of debrisoquine 

  27. Clin. Pharmacol. Ther. Dalen 63 444 1998 10.1016/S0009-9236(98)90040-6 10-Hydroxylation of nortriptyline in Caucasians with 0, 1, 2, 3 and 13 functional CYP2D6 genes 

  28. Psychopharmacology Dahl 123 315 1996 10.1007/BF02246640 Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype 

  29. J. Clin. Psychopharmacol. Morita 20 141 2000 10.1097/00004714-200004000-00005 Steady-state plasma levels of nortriptyline and its hydroxylated metabolites in Japanese patients: Impact of CYP2D6 genotype on the hydroxylation of nortriptyline 

  30. Lancet Bertilsson 1 560 1982 Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implication 

  31. Sjoqvist 359 1984 Frontiers in Biochemical and Pharmacological Research in Depression Clinical pharmacology of antidepressant drugs: pharmacogenetics 

  32. Ther. Drug Monit. Llerena 14 92 1992 10.1097/00007691-199204000-00003 Haloperidol disposition is dependent of debrisoquine hydroxylation phenotype 

  33. Am. J. Psychiatry Nyberg 152 173 1995 10.1176/ajp.152.2.173 D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate 

  34. Pharmacogenetics Suzuki 7 415 1997 10.1097/00008571-199710000-00013 Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients 

  35. Clin. Pharmacol. Ther. Mihara 65 291 1999 10.1016/S0009-9236(99)70108-6 Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia 

  36. Br. J. Clin. Pharmacol. Roh 52 265 2001 10.1046/j.0306-5251.2001.01437.x Plasma concentrations of haloperidol are related to the CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients 

  37. Pharmacogenetics Griese 8 15 1998 10.1097/00008571-199802000-00003 Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population 

  38. Pharmacogenetics Raimundo 10 577 2000 10.1097/00008571-200010000-00001 Elucidation of the genetic basis of the common ‘intermediate metabolizer’ phenotype for drug oxidation by CYP2D6 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로